Moreover, we erased the T2DM participants diagnosed with EC within 6 months after SGLT2 inhibitors administration, thus the time order between SGLT2 inhibitor administration and EC formation might be confirmed. Here, SLC5A2 is linked to type 2 diabetes mellitus.